- 9 Meters Biopharma Inc at William Blair Biotech Focus Conference TranscriptJul 12, 2022
- 9 Meters Biopharma Inc at BMO Biopharma Spotlight Series: Innovation in GI (Virtual) TranscriptAug 12, 2021
- 9 Meters Biopharma Inc Host KOL Perspectives on Short Bowel Syndrome & NM-002 Program Update Corporate Call TranscriptMar 23, 2021
- 9 Meters Biopharma, Inc. - Special Call TranscriptAug 18, 2020
- Innovate Biopharmaceuticals Inc R&D Day (Virtual) TranscriptMay 13, 2020
- Innovate Biopharmaceuticals, Inc., RDD Pharma, Ltd. - M&A Call TranscriptMay 04, 2020
- Innovate Biopharmaceuticals Inc Analyst Event to Discuss NASH Data and Provide Clinical Updates TranscriptMay 20, 2019
- Q1 2019 Innovate Biopharmaceuticals Inc Earnings Call TranscriptApr 29, 2019$32.4 (-14.74%)Earnings
- Q4 2018 Innovate Biopharmaceuticals Inc Earnings Call TranscriptMar 18, 2019Earnings
9 Meters Biopharma Inc Host KOL Perspectives on Short Bowel Syndrome & NM-002 Program Update Corporate Call Transcript
We brought 9 Meters together less than a year ago with the goal in mind of creating a company with an unwavering commitment to improving the lives of patients with debilitating GI disorders. As we go through our story today, we hope you will see we are truly on our way.
Here is the obligatory forward-looking statement with the appropriate safe harbors. Regarding our R&D Day agenda, you'll also get a quick introduction from myself, followed by an SBS overview and management from Dr. Patrick Griffin, our Chief Medical Officer. That will be followed by a topic called Clinical Impact of Chronic Diarrhea in SBS Patients by Carol Rees Parrish, who literally wrote the book, which you'll see. We will then go back to Patrick Griffin in terms of a paradigm shift from GLP-2s to GLP-1s. We will then recap our Phase Ib/IIa results and provide some additional data. And then we're very pleased, and most importantly, we believe, to share our clinical and regulatory path forward.
As I think you all saw in the press release, the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)